Nianping Hu

1.8k total citations · 1 hit paper
21 papers, 1.2k citations indexed

About

Nianping Hu is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and General Health Professions. According to data from OpenAlex, Nianping Hu has authored 21 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Endocrinology, Diabetes and Metabolism and 4 papers in General Health Professions. Recurrent topics in Nianping Hu's work include Diabetes Treatment and Management (6 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Diabetes Management and Research (3 papers). Nianping Hu is often cited by papers focused on Diabetes Treatment and Management (6 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Diabetes Management and Research (3 papers). Nianping Hu collaborates with scholars based in Canada, Germany and United States. Nianping Hu's co-authors include John C. Bell, Meixia Bi, Heather P. Harding, Donalyn Scheuner, Jaime D. Blais, Diane Fels, James A. Raleigh, Marianne Koritzinsky, Bradly G. Wouters and David Ron and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

Nianping Hu

19 papers receiving 1.2k citations

Hit Papers

ER stress‐regulated translation increases tolerance to ex... 2005 2026 2012 2019 2005 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. ER stress‐regulated translation increases tolerance to extreme hypoxia and promotes tumor growth
    2005 574 citations Meixia Bi, Christine Naczki et al. The EMBO Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nianping Hu Canada 11 514 395 317 291 191 21 1.2k
Tjeerd Sijmonsma Germany 21 541 1.1× 98 0.2× 234 0.7× 386 1.3× 204 1.1× 27 1.4k
Narcissus Teoh Australia 12 361 0.7× 137 0.3× 177 0.6× 529 1.8× 280 1.5× 17 1.1k
Maria Ida Amabile Italy 19 354 0.7× 223 0.6× 129 0.4× 84 0.3× 203 1.1× 74 1.2k
Peter Dietrich Germany 21 543 1.1× 72 0.2× 159 0.5× 387 1.3× 197 1.0× 50 1.3k
Sara Heebøll Denmark 14 365 0.7× 104 0.3× 247 0.8× 575 2.0× 138 0.7× 32 1.1k
Kei Moriya Japan 16 364 0.7× 62 0.2× 198 0.6× 478 1.6× 203 1.1× 61 1.2k
Antoine Pilon France 14 419 0.8× 139 0.4× 137 0.4× 122 0.4× 232 1.2× 24 744
Sander Lefere Belgium 18 274 0.5× 98 0.2× 213 0.7× 789 2.7× 260 1.4× 55 1.2k
Morgane Baron France 9 422 0.8× 75 0.2× 171 0.5× 484 1.7× 159 0.8× 16 986
Shuguang Yuan China 19 672 1.3× 83 0.2× 115 0.4× 185 0.6× 159 0.8× 43 1.4k

Countries citing papers authored by Nianping Hu

Since Specialization
Citations

This map shows the geographic impact of Nianping Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nianping Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nianping Hu more than expected).

Fields of papers citing papers by Nianping Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nianping Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nianping Hu. The network helps show where Nianping Hu may publish in the future.

Co-authorship network of co-authors of Nianping Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Nianping Hu. A scholar is included among the top collaborators of Nianping Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nianping Hu. Nianping Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Penz, Erika, et al.. (2021). Economic Burden of Chronic Obstructive Pulmonary Disease and Lung Cancer Between 2000 and 2015 in Saskatchewan: Study Protocol. JMIR Research Protocols. 11(3). e31350–e31350. 1 indexed citations
3.
Lix, Lisa M., Jean-Marc Daigle, Anat Fisher, et al.. (2021). Validity of an algorithm to identify cardiovascular deaths from administrative health records: a multi-database population-based cohort study. BMC Health Services Research. 21(1). 758–758. 8 indexed citations
4.
Filion, Kristian B., Lisa M. Lix, Sophie Dell’Aniello, et al.. (2020). Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study. BMJ. 370. m3342–m3342. 78 indexed citations
5.
Hu, Nianping, Christine Naczki, James A. Raleigh, et al.. (2020). ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. UNC Libraries. 1 indexed citations
6.
Fisher, Anat, Michael Fralick, Kristian B. Filion, et al.. (2020). Sodium‐glucose co‐transporter‐2 inhibitors and the risk of urosepsis: A multi‐site, prevalent new‐user cohort study. Diabetes Obesity and Metabolism. 22(9). 1648–1658. 24 indexed citations
7.
Douros, Antonios, Lisa M. Lix, Michael Fralick, et al.. (2020). Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis. Annals of Internal Medicine. 173(6). 417–425. 118 indexed citations
8.
Secrest, Matthew H., Laurent Azoulay, Matthew Dahl, et al.. (2019). A population‐based analysis of antidiabetic medications in four Canadian provinces: Secular trends and prescribing patterns. Pharmacoepidemiology and Drug Safety. 29(S1). 86–92. 11 indexed citations
9.
Hu, Nianping, et al.. (2017). Uptake of the Medication Assessment Program in Saskatchewan: Tracking claims during the first year. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 151(1). 24–28. 3 indexed citations
10.
Filion, Kristian B., Laurent Azoulay, Robert W. Platt, et al.. (2016). A Multicenter Observational Study of Incretin-based Drugs and Heart Failure. New England Journal of Medicine. 374(12). 1145–1154. 173 indexed citations
11.
12.
13.
Lix, Lisa M., Lin Yan, David Blackburn, et al.. (2014). Validity of the RAI-MDS for ascertaining diabetes and comorbid conditions in long-term care facility residents. BMC Health Services Research. 14(1). 17–17. 16 indexed citations
14.
Chapman, Judith‐Anne W., Chris J. O’Callaghan, Nianping Hu, et al.. (2013). Innovative estimation of survival using log-normal survival modelling on ACCENT database. British Journal of Cancer. 108(4). 784–790. 17 indexed citations
15.
Hu, Nianping, et al.. (2012). Potential therapeutic applications of phosphodiesterase inhibition in prostate cancer. World Journal of Urology. 31(2). 325–330. 38 indexed citations
16.
Rajput, Ashish, Nianping Hu, Sonal Varma, et al.. (2011). Immunohistochemical Assessment of Expression of Centromere Protein—A (CENPA) in Human Invasive Breast Cancer. Cancers. 3(4). 4212–4227. 38 indexed citations
17.
Chapman, Judith‐Anne W., Chris J. O’Callaghan, Nianping Hu, et al.. (2011). Comparison of innovative estimation of efficacy to standard using the ACCENT database.. Journal of Clinical Oncology. 29(15_suppl). 3616–3616. 4 indexed citations
18.
Siemens, D. Robert, Nianping Hu, Abdolkarim Sheikhi, et al.. (2008). Hypoxia Increases Tumor Cell Shedding of MHC Class I Chain-Related Molecule: Role of Nitric Oxide. Cancer Research. 68(12). 4746–4753. 100 indexed citations
19.
20.
Bi, Meixia, Christine Naczki, Marianne Koritzinsky, et al.. (2005). ER stress‐regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. The EMBO Journal. 24(19). 3470–3481. 574 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tjeerd Sijmonsma Breakdown of academic impact, for papers by Narcissus Teoh Breakdown of academic impact, for papers by Maria Ida Amabile Breakdown of academic impact, for papers by Peter Dietrich Breakdown of academic impact, for papers by Sara Heebøll Breakdown of academic impact, for papers by Kei Moriya Breakdown of academic impact, for papers by Antoine Pilon Breakdown of academic impact, for papers by Sander Lefere Breakdown of academic impact, for papers by Morgane Baron Breakdown of academic impact, for papers by Shuguang Yuan
Rankless by CCL
2026